 Connection
Anna Baron to Aged, 80 and over
This is a "connection" page, showing publications Anna Baron has written about Aged, 80 and over.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.499 |
|
|
|
-
Asundi A, Stanislawski M, Mehta P, Mull HJ, Schweizer ML, Bar?n AE, Ho PM, Gupta K, Branch-Elliman W. Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program. Sci Rep. 2020 03 24; 10(1):5276.
Score: 0.080
-
Burke RE, Canamucio A, Glorioso TJ, Bar?n AE, Ryskina KL. Transitional Care Outcomes in Veterans Receiving Post-Acute Care in a Skilled Nursing Facility. J Am Geriatr Soc. 2019 09; 67(9):1820-1826.
Score: 0.075
-
Asundi A, Stanislawski M, Mehta P, Bar?n AE, Gold H, Mull H, Ho PM, Gupta K, Branch-Elliman W. Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program. Infect Control Hosp Epidemiol. 2018 09; 39(9):1030-1036.
Score: 0.072
-
Burke RE, Hess E, Bar?n AE, Levy C, Donz? JD. Predicting Potential Adverse Events During a Skilled Nursing Facility Stay: A Skilled Nursing Facility Prognosis Score. J Am Geriatr Soc. 2018 05; 66(5):930-936.
Score: 0.069
-
Branch-Elliman W, Stanislawski M, Strymish J, Bar?n AE, Gupta K, Varosy PD, Gold HS, Ho PM. Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement? Infect Control Hosp Epidemiol. 2016 09; 37(9):1005-11.
Score: 0.062
-
Jones CD, Falvey J, Hess E, Levy CR, Nuccio E, Bar?n AE, Masoudi FA, Stevens-Lapsley J. Predicting Hospital Readmissions from Home Healthcare in Medicare Beneficiaries. J Am Geriatr Soc. 2019 12; 67(12):2505-2510.
Score: 0.019
-
Asundi A, Stanislawski M, Mehta P, Baron AE, Mull HJ, Ho PM, Zimetbaum PJ, Gupta K, Branch-Elliman W. Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program. Infect Control Hosp Epidemiol. 2019 08; 40(8):855-862.
Score: 0.019
-
Leary PJ, Hess E, Bar?n AE, Branch KR, Choudhary G, Hough CL, Maron BA, Ralph DD, Ryan JJ, Tedford RJ, Weiss NS, Zamanian RT, Lahm T. H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program. Am J Respir Crit Care Med. 2018 06 15; 197(12):1638-1641.
Score: 0.018
-
Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, Swenson ER, Goldstein RH, Leopold JA, Zamanian RT, Elwing JM, Plomondon ME, Grunwald GK, Bar?n AE, Rumsfeld JS, Choudhary G. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016 Mar 29; 133(13):1240-8.
Score: 0.015
-
Merrick DT, Gao D, Miller YE, Keith RL, Baron AE, Feser W, Kennedy TC, Blatchford PJ, Braudrick S, Hirsch FR, Heasley L, Bunn PA, Franklin WA. Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma. Cancer Prev Res (Phila). 2016 Jan; 9(1):96-104.
Score: 0.015
-
Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, Bradley SM, Maddox TM, Grunwald GK, Bar?n AE, Rumsfeld JS, Varosy PD, Schneider PM, Marzec LN, Ho PM. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. Am Heart J. 2014 Jun; 167(6):810-7.
Score: 0.013
-
Clarke CL, Grunwald GK, Allen LA, Bar?n AE, Peterson PN, Brand DW, Magid DJ, Masoudi FA. Natural history of left ventricular ejection fraction in patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):680-6.
Score: 0.013
-
Schenkman M, Ellis T, Christiansen C, Bar?n AE, Tickle-Degnen L, Hall DA, Wagenaar R. Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease. Phys Ther. 2011 Sep; 91(9):1339-54.
Score: 0.011
-
Lam ET, O'Bryant CL, Basche M, Gustafson DL, Serkova N, Baron A, Holden SN, Dancey J, Eckhardt SG, Gore L. A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors. Mol Cancer Ther. 2008 Dec; 7(12):3685-94.
Score: 0.009
-
Andreeff M, Ruvolo V, Gadgil S, Zeng C, Coombes K, Chen W, Kornblau S, Bar?n AE, Drabkin HA. HOX expression patterns identify a common signature for favorable AML. Leukemia. 2008 Nov; 22(11):2041-7.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|